Hematology and oncology are not the same thing, but they overlap so much that they’re often practiced together as a single combined specialty. Hematology is the study of blood and blood-forming organs. Oncology is the study and treatment of cancer. Where they meet is in blood cancers like leukemia, lymphoma, and myeloma, which are both blood disorders and cancers at the same time. That overlap is why most doctors in this space train in both fields and why you’ll often see “hematology/oncology” listed as one department.
What Each Field Actually Covers
Hematology deals with everything related to blood: red cells, white cells, platelets, clotting proteins, and the bone marrow that produces them. Many of the conditions hematologists treat have nothing to do with cancer. Anemia is the most common noncancerous blood disorder. Others include hemophilia (a genetic condition that prevents normal clotting), von Willebrand disease (the most common bleeding disorder in the U.S.), sickle cell anemia, and thrombocytopenia (low platelet counts). Clotting disorders like Factor V Leiden, which raises the risk of dangerous blood clots, also fall squarely in hematology’s territory.
Oncology, by contrast, is focused on cancer. Medical oncologists diagnose and treat solid tumors: cancers of the breast, lung, colon, prostate, and other organs. These are carcinomas and sarcomas, growths that form masses in tissue. The tools are different too. Oncologists rely heavily on imaging studies and tissue biopsies to identify and stage tumors, while hematologists lean on blood tests, bone marrow biopsies, and lab work to evaluate what’s happening in the blood and marrow.
Where the Two Fields Overlap
Blood cancers sit right at the intersection. Leukemia starts in the bone marrow and floods the bloodstream with abnormal white cells. Lymphoma arises in the lymphatic system. Myeloma attacks plasma cells in the bone marrow. These conditions are hematologic (they involve blood and marrow) and oncologic (they are cancers) at the same time. A doctor treating lymphoma needs to understand both cancer biology and how the blood system works.
This shared territory is the main reason the two specialties merged in practice. Treatment for blood cancers tends to be especially intensive. Patients with hematologic malignancies are more likely to receive aggressive, cure-oriented therapies like multi-drug chemotherapy regimens and stem cell transplants. These treatments carry serious side effects, including infections, severe anemia, bleeding, and blood clots, all of which require deep hematology expertise to manage. Newer therapies like CAR T-cell treatment, which reprograms a patient’s own immune cells to attack cancer, bring their own unique and serious complications that demand specialized monitoring.
Why Doctors Usually Train in Both
In the U.S., hematology and oncology are typically learned together in a single three-year fellowship after internal medicine residency. During that training, fellows rotate through benign hematology (noncancerous blood disorders), malignant hematology (blood cancers), and solid tumor oncology. The structure reflects how intertwined the two fields are in daily practice.
That said, some programs do offer single-board tracks. A fellow can choose to certify only in hematology or only in medical oncology, with the option to extend training by about six months to earn dual certification. At institutions like the one described by the American Society of Hematology, the hematology-only track still includes significant training in blood cancers, because you can’t practice hematology without encountering them. Similarly, the oncology-only track includes malignant hematology training alongside solid tumor work.
In practice, most physicians board-certify in both. Some then specialize further. A hematologist at a sickle cell clinic may rarely see cancer patients. An oncologist at a breast cancer center may rarely manage clotting disorders. But the foundational training covers both fields.
How Referrals Differ
The reason you’re sent to one type of specialist versus another depends on what your primary care doctor finds. If a routine blood test shows a single abnormality like mild anemia, most primary care physicians investigate on their own first. Only about 4% refer to a hematologist after a first anemia finding. But when blood work shows multiple problems at once, referral rates jump sharply. If anemia appears alongside pancytopenia (low counts across all blood cell types), nearly 89% of primary care doctors refer to hematology. Low white cells or low platelets alongside anemia trigger referrals about 64% of the time.
Signs that suggest a possible lymphoma, like swollen lymph nodes or unexplained night sweats, prompt referrals less urgently, at around 25% to 43%. Lab abnormalities pointing toward leukemia or bone marrow failure tend to get faster referrals because they can progress quickly and the diagnosis requires bone marrow evaluation that only a hematologist typically performs.
If a solid tumor is suspected, say from an abnormal mammogram or a mass found on a CT scan, you’d be referred to a medical oncologist or a surgical oncologist, not a hematologist. The diagnostic path involves tissue biopsies and imaging rather than blood work and marrow samples.
What This Means for You as a Patient
If your doctor refers you to a “hematologist/oncologist,” it doesn’t automatically mean you have cancer. Many patients see these specialists for entirely noncancerous conditions: unexplained anemia, abnormal clotting, unusual bruising, or chronically low blood counts. The dual title reflects the doctor’s training, not your diagnosis.
If you do have a blood cancer, your specialist will draw on both sides of their training, using hematology skills to interpret your blood work and manage complications while applying oncology expertise to plan chemotherapy, immunotherapy, or transplant. For solid tumors like lung or colon cancer, your oncologist handles treatment planning and systemic therapy, and a hematologist may get involved only if blood-related complications arise.
Stem cell and bone marrow transplants are one area where the hematology side of the specialty dominates regardless of the underlying disease. These procedures, used for blood cancers, certain solid tumors, and some immune disorders, are overseen by transplant hematologists who specialize in replacing a patient’s blood-forming system. It’s one of the most intensive treatments in medicine, and the expertise required sits firmly at the intersection of both fields.